🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Large cap stock jumps after it received order of upto ₹ 2,500 Cr from Asian Institute of Gastroenterology

Published 18-06-2024, 01:44 pm
Large cap stock jumps after it received order of upto ₹ 2,500 Cr from Asian Institute of Gastroenterology

Leading Multinational Conglomerate which is one of the leading players in domestic and overseas Markets, for providing EPC Solutions across various sectors in focus upon receiving a work order of upto Rs. 2,500 Crores for constructing a super-specialty hospital and many more.

With a market capitalization of Rs. 5,08,659 Crores, the shares of Larsen & Toubro Limited were trading at Rs. 3,700 per equity share, up 0.36 percent from its previous day’s close price of Rs. 3,686.75.

Is L&T a buy or sell? Click here to get an InvestingPro subscription for a special discount of 69% at an unbelievable price of only Rs 196 per month

The above link works best from a laptop/desktop and not apps.

Larsen & Toubro Limited through L&T Construction’s Buildings & Factories (B&F) vertical has received a significant work order worth Rs. 1,000- 2,500 Crores from the Asian Institute of Gastroenterology, Hyderabad.

The work order involves the construction of a super-specialty hospital at Gachibowli over a total built-up area of 1.1 mn sq ft. The scope includes civil structures, finishes, facades, interiors, MEP services, and paramedical and external development jobs, including landscaping.

Further, it has secured another order from a prestigious client for the construction of office space in Mumbai with an approximate built-up area of 13 lakh sq ft. The scope includes civil and composite steel structures for 2B+G+6P+18 office floors. The project is scheduled to be completed in 20 months

Larsen & Toubro Limited is a multinational conglomerate operating in over 50 countries, it is primarily engaged in providing engineering, procurement, and construction (EPC) solutions across major sectors such as Hydrocarbon, Power, Infrastructure, Information Technology, Defence, and Financial Services in domestic and international markets.

It has a strong order book worth Rs. 4,758 Billion, of which International orders are 61.97 percent (Rs. 2949 Billion) and Domestic orders are 38.02 percent (Rs. 1,809 Billion).

The segmental order breakup is as follows Infrastructure projects 65 percent, Energy 25 percent, Hi-Tech manufacturing 7 percent, and others 3 percent. As per the geography, 62 percent are domestic projects, 35 percent in the Middle East, USA & Europe 0.3 percent, and 3 percent in the rest of the world.

As for the revenue breakdown, It generates 51 percent of its revenue from the Infrastructure segment, 29 percent from services, 13 percent from energy, 4 percent from Hi-Tech manufacturing, and 3 percent from other segments.

Its Revenue from Operations grew by 7.67 percent from Rs. 36,734 Crores in Q4FY23 to Rs. 39,553 Crores in Q4FY24, accompanied by profits of Rs. 3,002.85 Crores to Rs. 2,666.07 Crores.

Introducing InvestingPro

Through InvestingPro, you can beat the markets with premium insights:

  • Find Undervalued/Overvalued Stocks: Reveal the unbiased Fair Value of any stock based on 1,200+ premium metrics, covering 180,000+ companies worldwide.
  • Instant Financial Bottom Line: Make fully-informed investing decisions with ProTips, bite-size insights that flag risks and rewards on any stock.
  • Discover Overlooked Stocks With Pre-Built Screeners: Find the ideal value stocks to match your investing style, all based on 100% trusted data.
  • Get AI-Enhanced Stock Picks: Receive regularly updated ProPicks for any investing strategy, each with a proven track record to beat the S&P 500
  • Boost Your Picks with Data: Instantly see a company's long-term sustainability and Financial Health to know if it's truly a solid investment.
  • Always Pick the Winner: Make instant Peer Comparisons based on over a dozen valuation benchmarks to ensure you always select a top dog.
  • Get Ideas From Top-Performing Portfolios: See the investments of any firm, fund or private investor with over $100 million in holding assets to discover new ideas.

Now, coming to the great news! For the benefit of our users, we have reduced the prices on all of our Pro and Pro+ plans by almost 69% for a limited period.

Click here to get an InvestingPro subscription for a special discount of 69% at an unbelievable price of only Rs 196 per month

The above link works best from a laptop/desktop and not apps.

Written by: Bharath K.S


The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Large cap stock jumps after it received order of upto ₹ 2,500 Cr from Asian Institute of Gastroenterology appeared first on Trade Brains.

Read More

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.